Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 22120172)

1.

Reverse engineering an amyloid aggregation pathway with dimensional analysis and scaling.

Bailey J, Potter KJ, Verchere CB, Edelstein-Keshet L, Coombs D.

Phys Biol. 2011 Dec;8(6):066009. doi: 10.1088/1478-3975/8/6/066009. Epub 2011 Nov 25.

2.

Structural polymorphism of human islet amyloid polypeptide (hIAPP) oligomers highlights the importance of interfacial residue interactions.

Zhao J, Yu X, Liang G, Zheng J.

Biomacromolecules. 2011 Jan 10;12(1):210-20. doi: 10.1021/bm101159p. Epub 2010 Dec 15.

PMID:
21158384
3.

Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.

Sasahara K, Morigaki K, Okazaki T, Hamada D.

Biochemistry. 2012 Sep 4;51(35):6908-19. doi: 10.1021/bi300542g. Epub 2012 Aug 23.

PMID:
22876830
4.

Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.

Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter W, Brunner H, Kapurniotu A.

J Mol Biol. 2000 Jan 28;295(4):1055-71.

PMID:
10656810
5.

Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Engel MF, Khemtémourian L, Kleijer CC, Meeldijk HJ, Jacobs J, Verkleij AJ, de Kruijff B, Killian JA, Höppener JW.

Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6033-8. doi: 10.1073/pnas.0708354105. Epub 2008 Apr 11.

6.

Amyloid aggregation and deposition of human islet amyloid polypeptide at membrane interfaces.

Sasahara K, Morigaki K, Shinya K.

FEBS J. 2014 Jun;281(11):2597-612. doi: 10.1111/febs.12807. Epub 2014 Apr 30.

PMID:
24702784
7.
8.

The molecular basis of distinct aggregation pathways of islet amyloid polypeptide.

Wei L, Jiang P, Xu W, Li H, Zhang H, Yan L, Chan-Park MB, Liu XW, Tang K, Mu Y, Pervushin K.

J Biol Chem. 2011 Feb 25;286(8):6291-300. doi: 10.1074/jbc.M110.166678. Epub 2010 Dec 10.

9.
10.

Nucleobindin 1 caps human islet amyloid polypeptide protofibrils to prevent amyloid fibril formation.

Gupta R, Kapoor N, Raleigh DP, Sakmar TP.

J Mol Biol. 2012 Aug 10;421(2-3):378-89. doi: 10.1016/j.jmb.2012.04.017. Epub 2012 Apr 24.

11.

How type II diabetes-related islet amyloid polypeptide damages lipid bilayers.

Lee CC, Sun Y, Huang HW.

Biophys J. 2012 Mar 7;102(5):1059-68. doi: 10.1016/j.bpj.2012.01.039. Epub 2012 Mar 6.

12.

Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide.

Rhoades E, Agarwal J, Gafni A.

Biochim Biophys Acta. 2000 Feb 9;1476(2):230-8.

PMID:
10669788
13.

Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro.

Khemtémourian L, Lahoz Casarramona G, Suylen DP, Hackeng TM, Meeldijk JD, de Kruijff B, Höppener JW, Killian JA.

Biochemistry. 2009 Nov 24;48(46):10918-25. doi: 10.1021/bi901076d.

PMID:
19817482
14.
15.

Ruthenium complexes as novel inhibitors of human islet amyloid polypeptide fibril formation.

He L, Wang X, Zhao C, Wang H, Du W.

Metallomics. 2013 Dec;5(12):1599-603. doi: 10.1039/c3mt00146f. Epub 2013 Sep 3.

PMID:
24056501
16.

Interaction of hIAPP with model raft membranes and pancreatic beta-cells: cytotoxicity of hIAPP oligomers.

Weise K, Radovan D, Gohlke A, Opitz N, Winter R.

Chembiochem. 2010 Jun 14;11(9):1280-90. doi: 10.1002/cbic.201000039.

PMID:
20440729
17.

Existence of different structural intermediates on the fibrillation pathway of human serum albumin.

Juárez J, Taboada P, Mosquera V.

Biophys J. 2009 Mar 18;96(6):2353-70. doi: 10.1016/j.bpj.2008.12.3901.

18.

Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide.

Cheng B, Gong H, Li X, Sun Y, Zhang X, Chen H, Liu X, Zheng L, Huang K.

Biochem Biophys Res Commun. 2012 Mar 16;419(3):495-9. doi: 10.1016/j.bbrc.2012.02.042. Epub 2012 Feb 14.

PMID:
22366091
19.

Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP.

Meier JJ, Kayed R, Lin CY, Gurlo T, Haataja L, Jayasinghe S, Langen R, Glabe CG, Butler PC.

Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1317-24. Epub 2006 Jul 18.

20.

Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.

Sellin D, Yan LM, Kapurniotu A, Winter R.

Biophys Chem. 2010 Aug;150(1-3):73-9. doi: 10.1016/j.bpc.2010.01.006. Epub 2010 Jan 28.

PMID:
20153100
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk